Research programme: seasonal influenza vaccines - AmVacAlternative Names: AMV 401; FluVac - AmVac; Influenza vaccine - AmVac/Bayer Innovation GmbH; Universal influenza vaccine - AmVac
Latest Information Update: 02 Dec 2014
At a glance
- Originator AmVac
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Influenza virus infections